small molecule

DESOGEN

DESOGESTREL; ETHINYL ESTRADIOL

Loss of exclusivity—loss of exclusivity

CompanyOrganon →See this company's full patent-cliff portfolio

Drug detail

Brand name	DESOGEN
Active ingredient	DESOGESTREL; ETHINYL ESTRADIOL
Strength	0.15MG;0.03MG
Dosage form	TABLET
Route	ORAL-28
Modality	Small molecule
FDA approval	December 1992
Marketing status	DISCN

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.